Corrigendum: PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma

Annalisa D'Avola; Nathalie Legrave; Mylène Tajan; Probir Chakravarty; Ryan L. Shearer; Hamish W. King; Katarina Kluckova; Eric C. Cheung; Andrew J. Clear; Arief S. Gunawan; Lingling Zhang; Louisa K. James; James I. MacRae; John G. Gribben; Dinis P. Calado; Karen H. Vousden; John C. Riches

doi:10.1172/JCI179917

Corrigendum: PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma

Annalisa D'Avola, Nathalie Legrave, Mylène Tajan, Probir Chakravarty, Ryan L. Shearer, Hamish W. King, Katarina Kluckova, Eric C. Cheung, Andrew J. Clear, Arief S. Gunawan, Lingling Zhang, Louisa K. James, James I. MacRae, John G. Gribben, Dinis P. Calado, Karen H. Vousden, John C. Riches^*

^*Corresponding author for this work

Metabolomics Platform

Research output: Contribution to journal › Article › Research › peer-review

1 Citation (Scopus)

Original language	English
Journal	Journal of Clinical Investigation
Volume	134
Issue number	4
DOIs	https://doi.org/10.1172/JCI179917
Publication status	Published - 15 Feb 2024

Access to Document

10.1172/JCI179917Licence: CC BY

Cite this

D'Avola, A., Legrave, N., Tajan, M., Chakravarty, P., Shearer, R. L., King, H. W., Kluckova, K., Cheung, E. C., Clear, A. J., Gunawan, A. S., Zhang, L., James, L. K., MacRae, J. I., Gribben, J. G., Calado, D. P., Vousden, K. H., & Riches, J. C. (2024). Corrigendum: PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. Journal of Clinical Investigation, 134(4). https://doi.org/10.1172/JCI179917

@article{acac4aeab3894c26ae56e09646a4d6da,

title = "Corrigendum: PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma",

author = "Annalisa D'Avola and Nathalie Legrave and Myl{\`e}ne Tajan and Probir Chakravarty and Shearer, {Ryan L.} and King, {Hamish W.} and Katarina Kluckova and Cheung, {Eric C.} and Clear, {Andrew J.} and Gunawan, {Arief S.} and Lingling Zhang and James, {Louisa K.} and MacRae, {James I.} and Gribben, {John G.} and Calado, {Dinis P.} and Vousden, {Karen H.} and Riches, {John C.}",

note = "Acknowledgments The authors are very grateful to all of the patients who generously donated their tissue to the tissue biobank. We also thank Kamil Kranc for his thorough review of the manuscript. In addition, we thank Riken for the B6;129P2-Phgdh<tm2Bsi> (Phgdh fl ) mice and Raze Therapeutics for providing PH-755. This work was supported by fellowships and grants from the Wellcome Trust (110020/Z/15/Z to JCR; 213555/Z/18/Z to HWK) and Cancer Research UK (C596/A26855 to KHV). In addition, this work was supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001557, FC001057), the United Kingdom Medical Research Council (FC001557, FC001057), and the Wellcome Trust (FC001557, FC001057), and by Barts Cancer Institute, which receives funding from a Cancer Research UK Centre Grant (C355/A25137). For the purpose of open access, the authors have applied a CC-BY public copyright licence to any Author Accepted Manuscript version arising from this submission",

year = "2024",

month = feb,

day = "15",

doi = "10.1172/JCI179917",

language = "English",

volume = "134",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "American Society for Clinical Investigation",

number = "4",

}

D'Avola, A, Legrave, N, Tajan, M, Chakravarty, P, Shearer, RL, King, HW, Kluckova, K, Cheung, EC, Clear, AJ, Gunawan, AS, Zhang, L, James, LK, MacRae, JI, Gribben, JG, Calado, DP, Vousden, KH & Riches, JC 2024, 'Corrigendum: PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma', Journal of Clinical Investigation, vol. 134, no. 4. https://doi.org/10.1172/JCI179917

TY - JOUR

T1 - Corrigendum: PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma

AU - D'Avola, Annalisa

AU - Legrave, Nathalie

AU - Tajan, Mylène

AU - Chakravarty, Probir

AU - Shearer, Ryan L.

AU - King, Hamish W.

AU - Kluckova, Katarina

AU - Cheung, Eric C.

AU - Clear, Andrew J.

AU - Gunawan, Arief S.

AU - Zhang, Lingling

AU - James, Louisa K.

AU - MacRae, James I.

AU - Gribben, John G.

AU - Calado, Dinis P.

AU - Vousden, Karen H.

AU - Riches, John C.

N1 - Acknowledgments The authors are very grateful to all of the patients who generously donated their tissue to the tissue biobank. We also thank Kamil Kranc for his thorough review of the manuscript. In addition, we thank Riken for the B6;129P2-Phgdh<tm2Bsi> (Phgdh fl ) mice and Raze Therapeutics for providing PH-755. This work was supported by fellowships and grants from the Wellcome Trust (110020/Z/15/Z to JCR; 213555/Z/18/Z to HWK) and Cancer Research UK (C596/A26855 to KHV). In addition, this work was supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001557, FC001057), the United Kingdom Medical Research Council (FC001557, FC001057), and the Wellcome Trust (FC001557, FC001057), and by Barts Cancer Institute, which receives funding from a Cancer Research UK Centre Grant (C355/A25137). For the purpose of open access, the authors have applied a CC-BY public copyright licence to any Author Accepted Manuscript version arising from this submission

PY - 2024/2/15

Y1 - 2024/2/15

UR - http://www.scopus.com/inward/record.url?scp=85185342291&partnerID=8YFLogxK

U2 - 10.1172/JCI179917

DO - 10.1172/JCI179917

M3 - Article

C2 - 38357928

AN - SCOPUS:85185342291

SN - 0021-9738

VL - 134

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 4

ER -

Corrigendum: PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma

Access to Document

Other files and links

Cite this